About Bio-Conscious Technologies
Bio-Conscious Technologies is a healthcare AI company dedicated to transforming glucose data into actionable insights for proactive health management. Their flagship platform, Endobits, is a clinician-facing tool that aggregates continuous glucose monitoring (CGM) data and applies multi-layered AI models to forecast glucose events. This allows for the prioritization of patients by risk and provides decision support and automated documentation, ultimately aiming to prevent complications and improve outcomes for individuals with metabolic diseases like diabetes.
The Endobits platform is designed to shift clinical care from a reactive to a proactive approach by identifying and preventing disease altogether. It integrates data from various CGM devices, including Dexcom Share, Freestyle Libre, MiaoMiao 2, and Nightscout, and analyzes factors such as blood sugar levels, insulin doses, meals, exercise, and clinical test results. The system also clusters patients into distinct “glucotypes” based on the shape, timing, variability, and trajectory of their glucose curves, providing a more personalized understanding of metabolic phenotypes beyond just average glucose readings.
For physicians, Endobits offers a secure web portal that provides real-time patient information and prioritizes those at higher medical risk, enhancing remote patient monitoring and potentially reducing the need for unnecessary in-person appointments. The company’s AI-driven solutions have been presented at scientific sessions and aim to enhance therapeutic care, early intervention, and the understanding of metabolic health.
Focus Areas
Business Intelligence
| Technology | Cloud-native, AI operating system, deep learning for time-series forecasting, machine learning for event prediction, large language models (LLMs), API-based integrations, EHR/EMR interoperability, automated clinical documentation and billing tools, enterprise-grade encryption, PostgreSQL backend |
What Physicians Need to Know
For physicians, Bio-Conscious Technologies' Endobits platform offers automated CGM monitoring with a ranked worklist, rather than an overwhelming number of alerts, allowing for efficient patient prioritization. It provides decision support at the point of care, surfacing guideline-aligned next steps for diabetes management. The platform automates remote patient monitoring (RPM) services, including documentation and billing, which can increase clinical income and reduce administrative burden. Endobits can review an entire patient panel in seconds, significantly reducing the time clinicians spend on manual CGM chart review (which can take up to 45 minutes per patient). This allows specialists to focus on complex cases and helps clear backlogs without requiring new hires. The AI-driven insights can integrate directly with existing EHR systems, facilitating data-driven care coordination. The platform is also CGM-agnostic, compatible with devices from Dexcom, Abbott, and Senseonics.
Bio-Conscious Technologies emphasizes EHR/EMR interoperability and offers API integration services to connect clinical systems and third-party CGM data sources into electronic health records and analytics pipelines. The Endobits platform integrates with major EMR and EHR systems. They are compatible with continuous glucose monitors including Dexcom Share, Freestyle Libre, MiaoMiao 2, and Nightscout.
Reviews & Opinions
Videos
News, demos, and interviews about Bio-Conscious Technologies.
Videos load interactively. If none appear, search YouTube for Bio-Conscious Technologies →
Press & Coverage
Frequently Asked Questions
Comparisons
Related Companies
Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]
The University at Buffalo (UB) is a prominent public research university and a flagship institution of the State University of New York (SUNY) system. While UB itself is a broad academic institution, the provided URL (halsted.compbio.buffalo.edu) points to a specific area within UB focused on computational biology. This division is actively engaged in healthcare AI […]
Prenaital is an AI-driven healthcare company focused on revolutionizing maternal care by improving the early detection and management of high-risk pregnancies. Their AI models analyze ultrasound images to identify at-risk pregnancies, including those with abnormal fetal growth and a risk of preterm birth, with significantly higher accuracy than current clinical practices—detecting 25-50% more high-risk cases. […]
PHQ Screeners is a free, open-access resource maintained by Pfizer, providing a comprehensive suite of Patient Health Questionnaire (PHQ) and Generalized Anxiety Disorder (GAD-7) screening instruments. These tools were developed by Drs. Robert L. Spitzer, Janet B.W. Williams, and Kurt Kroenke with an educational grant from Pfizer, and are widely utilized in primary care and […]
NeurixaHealthAI™ is a healthcare AI company dedicated to eliminating administrative waste in the healthcare system, which they estimate to be $1.1 trillion annually. They offer a production-ready healthcare intelligence platform designed to simplify operations, improve outcomes, and accelerate the journey from patient care to financial performance. The platform is not a collection of point solutions […]